Many investors seemed to view Nvidia's decision to maintain its stake in Recursion as a vote of confidence in the company.

Hear the four bells with a history stretching back more than 100 years — plus, a special speaker for songs like “Hail Purdue!” Our STEM-focused urban campus is preparing students for the jobs of ...

Corbus Pharmaceuticals (CRBP) stock drops 12% after mixed Phase 1 trial results for its lead cancer candidate. Read more here.

Virpax completed a U.S. Army-backed Probudur study, showing potential for prolonged pain relief and reduced opioid use in surgical recovery.

Counseling and Psychological Services (CAPS) offers same-day/next-day services for any student seeking care with no predefined session limits and most services are free. Treatment services are brief ...

The shares have a fixed opening rate and closing rate. The share price for Marksans Pharma is ₹251.45 as on Feb 11, 2025. The market cap of Marksans Pharma is ₹12,412.16 Cr as on Feb 11 ...

Truist raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $520 from $460 and keeps a Buy rating on the shares. The firm is ...

Morgan Stanley analyst Terence Flynn raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $459 from $450 and keeps an Equal ...

Elite Pharmaceuticals, with a market capitalization of $531 million, reported a decline in third-quarter revenue for 2024, falling 8% from the previous year. Despite a strong nine-month performance, ...

Purdue Pharma and its controlling Sackler family have offered a new settlement to resolve lawsuits over their involvement in the opioid epidemic, raising the payout from the Sacklers to $6 billion.

Verona Pharma ... s long-term stock picks. Joseph Edelman is a renowned figure in the investment world, recognized for his expertise in biotechnology […] The average of price targets set ...